You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 119 No. 6, June 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Mechanisms of Ophthalmologic Disease
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (60)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Articles for Residents
 •Laser Surgery
 •Refractive Surgery
 •Alert me on articles by topic

The Wound Healing Response After Laser In Situ Keratomileusis and Photorefractive Keratectomy

Elusive Control of Biological Variability and Effect on Custom Laser Vision Correction

Steven E. Wilson, MD; Rahul R. Mohan, PhD; Jong-Wook Hong, MD; Jong-Soo Lee, MD; Rosan Choi, MD; Rajiv R. Mohan, PhD

Arch Ophthalmol. 2001;119:889-896.

Biological diversity in the wound healing response is thought to be a major factor limiting the predictability of the outcome of refractive surgical procedures such as laser in situ keratomileusis and photorefractive keratectomy. Corneal wound healing is critical to the success of topography-linked or wave front–linked excimer laser ablation to optimize visual performance. This is because of the importance of retaining subtle features of custom ablation and the tendency of epithelial hyperplasia and stromal remodeling to obscure these features following either procedure. The corneal wound healing response is exceedingly complex. Keratocyte apoptosis, which occurs in response to epithelial injury, is the earliest observable event in the wound healing cascades and is therefore an excellent target for pharmacological intervention. Alterations of surgical technique can be designed to limit keratocyte apoptosis and the subsequent events in corneal wound healing. Abnormalities of the cascades could contribute to the pathogenesis of corneal diseases. For example, recent data have suggested that perturbation of the keratocyte apoptosis/mitosis balance could underlie the development of keratoconus in a proportion of patients.


From the Departments of Ophthalmology, University of Washington, Seattle (Drs Wilson, Mohan, Hong, Lee, Choi, and Mohan); Korea University, Seoul (Dr Hong); and Medical Research Institute, Pusan National University, Pusan, Korea (Dr Lee). The authors have no proprietary interest in any of the products or materials mentioned in this article.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

An Interval-Censored Model for Predicting Myopic Regression after Laser In Situ Keratomileusis
Chen et al.
IOVS 2007;48:3516-3523.
ABSTRACT | FULL TEXT  

The Implications of the Upregulation of ICAM-1/VCAM-1 Expression of Corneal Fibroblasts on the Pathogenesis of Allergic Keratopathy
Okada et al.
IOVS 2005;46:4512-4518.
ABSTRACT | FULL TEXT  

Histologic, Ultrastructural, and Immunofluorescent Evaluation of Human Laser-Assisted In Situ Keratomileusis Corneal Wounds
Dawson et al.
Arch Ophthalmol 2005;123:741-756.
ABSTRACT | FULL TEXT  

Protective Effect of D-{beta}-Hydroxybutyrate on Corneal Epithelia in Dry Eye Conditions through Suppression of Apoptosis
Nakamura et al.
IOVS 2003;44:4682-4688.
ABSTRACT | FULL TEXT  

Keratocyte Density in the Human Cornea After Photorefractive Keratectomy
Erie et al.
Arch Ophthalmol 2003;121:770-776.
ABSTRACT | FULL TEXT  

Mitogenic and Antiapoptotic Effects of Various Growth Factors on Human Corneal Fibroblasts
Yanai et al.
IOVS 2002;43:2122-2126.
ABSTRACT | FULL TEXT  

Microarray Analysis of Corneal Fibroblast Gene Expression after Interleukin-1 Treatment
Mahajan et al.
IOVS 2002;43:2143-2151.
ABSTRACT | FULL TEXT  

Keratocyte Activation and Apoptosis in Transplanted Human Corneas in a Xenograft Model
Ohno et al.
IOVS 2002;43:1025-1031.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.